CD8A and neoplasm: IL‐17 exerted anti‐tumor functions by recruiting neutrophils, NK cells, and CD4+ and CD8+ T cells to tumor tissue and enhancing NK cell and cytotoxic T lymphocyte (CTL) activation (Qian et al., 2017).